SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial
SEASTAR ALERT: Bragar Eagel & Squire, P.C. is Investigating SeaStar Medical Holding Corp on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications
SeaStar Medical to Hold Business Update Conference Call on December 11, 2024
SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal Trial